INSURICA Named 2022 Best Agency to Work For by Insurance Journal Magazine
OKLAHOMA CITY – National publication Insurance Journal named INSURICA the Best Independent Agency to Work For in America following their annual survey of employees. The publication revealed the honor in their October 2022 issue.
According to the article published on Oct. 3, more than 3,500 customer service representatives responded to their survey. While INSURICA regularly appears on IJ’s list of vote getters, 2022 was the first time the agency appeared at the top of the list.
Mike Ross, INSURICA’s President and CEO, said the honor ranks among the biggest awards ever bestowed upon the agency in its history.
“We are thrilled with this honor,” Ross said. “I think the award serves as validation of our company’s commitment to INSURICA’s colleagues – our most valuable asset. Our ability to serve our clients with excellence begins with that commitment to our colleagues.”
Ross acknowledged the highly competitive post-COVID employment environment in which all insurance agencies find themselves today.
“It’s a challenge, retaining the years of experience we have here while hiring the next generation of INSURICAns to handle the needs of our growing agency,” Ross said. “I’m thankful for the culture that we’ve cultivated over the decades. It’s truly the foundation upon which this agency is built.”
The Insurance Journal article said INSURICA’s “community culture was a top rave given to the company by the dozens of employees who nominated the firm.”
About the Author
Share This Story
Related Blogs
RxDC Reporting: What Employers Should Do Before the June 1 Deadline
Each year, group health plans must report detailed prescription drug and healthcare spending data to the Centers for Medicare & Medicaid Services (CMS). This reporting—commonly referred to as RxDC reporting—is due by June 1 and applies to most employer-sponsored group health plans that offer prescription drug coverage.
Chronic Condition Management 2.0: GLP-1 Alternatives and New Digital Therapeutics
Chronic conditions have long been the primary driver of employer healthcare spending, but 2026 marks a turning point in how organizations are approaching prevention, treatment, and long-term management. With GLP-1 medications dominating headlines — and budgets — employers are urgently exploring complementary or alternative strategies that can improve outcomes without unsustainable cost growth. The result is a new wave of digital therapeutics, metabolic health programs, and integrated care models that promise a more balanced approach to chronic disease management.
The Return-to-Office Reset: How Benefits Are Being Re-Engineered in 2026
After several years of experimentation, many employers are tightening hybrid schedules or requiring more in-office days. This “return-to-office reset” is reshaping benefits strategies as organizations look for ways to support commuting employees, improve onsite experience, and maintain flexibility. What began as a workplace policy shift is now driving a broader rethinking of how benefits can reinforce culture, productivity, and retention.